Growth Metrics

Vertex Pharmaceuticals (VRTX) Gross Profit (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Revolution Medicines 31.20 Bn 31.20 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4.77%
Dec 31, 2025 2.34%
Sep 30, 2025 4.08%
Jun 30, 2025 6.23%
Mar 31, 2025 -3.27%
Dec 31, 2024 4.59%
Sep 30, 2024 4.64%
Jun 30, 2024 -3.16%
Mar 31, 2024 9.22%
Dec 31, 2023 -0.70%
Sep 30, 2023 -0.91%
Jun 30, 2023 3.64%
Mar 31, 2023 4.38%
Dec 31, 2022 -1.25%
Sep 30, 2022 5.71%
Jun 30, 2022 4.47%
Mar 31, 2022 1.45%
Dec 31, 2021 4.44%
Sep 30, 2021 11.64%
Jun 30, 2021 2.18%
Mar 31, 2021 7.53%
Dec 31, 2020 5.37%
Sep 30, 2020 0.90%
Jun 30, 2020 -0.93%
Mar 31, 2020 4,730.32%
Dec 31, 2019 -103.57%
Sep 30, 2019 1.53%
Jun 30, 2019 5.53%
Mar 31, 2019 2.08%
Dec 31, 2018 11.07%
Sep 30, 2018 3.94%
Jun 30, 2018 13.81%
Mar 31, 2018 0.28%
Dec 31, 2017 12.33%
Sep 30, 2017 6.84%
Jun 30, 2017 -29.17%
Mar 31, 2017 67.33%
Dec 31, 2016 11.95%
Sep 30, 2016 -6.56%
Jun 30, 2016 9.53%
Mar 31, 2016 1.11%
Dec 31, 2015 26.53%
Sep 30, 2015 80.69%
Jun 30, 2015 24.01%
Mar 31, 2015 -8.83%
Dec 31, 2014 5.02%
Sep 30, 2014 12.63%
Jun 30, 2014 2.53%
Mar 31, 2014 -4.90%
Dec 31, 2013 -42.70%
Sep 30, 2013 -12.36%
Jun 30, 2013 -22.63%
Mar 31, 2013 15.10%
Dec 31, 2012 -15.37%
Sep 30, 2012 -2.69%
Jun 30, 2012 -10.22%
Mar 31, 2012 -35.33%
Dec 31, 2011 40.62%